Concepedia

Nrf2 deficiency aggravates Angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6/STAT3-dependent inflammation

Dandan Chen, Zhe Li, Peiqing Bao, Miao Chen, Miao Zhang, Fangrong Yan, Yitao Xu, Caoyu Ji, Xinyue Hu, Daniel Sanchı́s,

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2019 · 52 citations · 47 references

DOI

Concepts

References

47

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

New England Journal of Medicine · 2000 · 8.7K citations · Full text

, , +16

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen et al. · The Lancet · 2002 · 5.4K citations

, , +13

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

The Lancet · 2001 · 3.2K citations · Full text

, , +12

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)

Kim Fox · The Lancet · 2003 · 2.2K citations

, , +13

STAT3 Regulates Cytokine-mediated Generation of Inflammatory Helper T Cells

Xuexian O. Yang, Athanasia D. Panopoulos, Roza Nurieva et al. · Journal of Biological Chemistry · 2007 · 1.5K citations · Full text

, , +17